Khuri FR - Search Results

1

Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.

Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, Benner SE, Winn R, Pajak TF, Williams B, Shenouda G, Hodson I, Fu K, Shin DM, Vokes EE, Feng L, Goepfert H, Hong WK. Khuri FR, et al. J Natl Cancer Inst. 2006 Apr 5;98(7):441-50. doi: 10.1093/jnci/djj091. J Natl Cancer Inst. 2006. PMID: 16595780 Clinical Trial.

2

Molecular epidemiology and retinoid chemoprevention of head and neck cancer.

Khuri FR, Lippman SM, Spitz MR, Lotan R, Hong WK. Khuri FR, et al. J Natl Cancer Inst. 1997 Feb 5;89(3):199-211. doi: 10.1093/jnci/89.3.199. J Natl Cancer Inst. 1997. PMID: 9017000 Review.

3

Clonal genetic alterations in the lungs of current and former smokers.

Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, Ro JY, Broxson A, Yu R, Morice RC, Kemp BL, Khuri FR, Walsh GL, Hittelman WN, Hong WK. Mao L, et al. Among authors: khuri fr. J Natl Cancer Inst. 1997 Jun 18;89(12):857-62. doi: 10.1093/jnci/89.12.857. J Natl Cancer Inst. 1997. PMID: 9196251

4

Chemoprevention of respiratory tract cancer.

Khuri FR, Kurie JM, Hong WK. Khuri FR, et al. Hematol Oncol Clin North Am. 1997 Jun;11(3):387-408. doi: 10.1016/s0889-8588(05)70440-8. Hematol Oncol Clin North Am. 1997. PMID: 9209902 Review.

5

Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer.

Spitz MR, McPherson RS, Jiang H, Hsu TC, Trizna Z, Lee JJ, Lippman SM, Khuri FR, Steffen-Batey L, Chamberlain RM, Schantz SP, Hong WK. Spitz MR, et al. Among authors: khuri fr. Cancer Epidemiol Biomarkers Prev. 1997 Sep;6(9):687-92. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9298575 Clinical Trial.

6

Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.

Shin DM, Glisson BS, Khuri FR, Ginsberg L, Lawhorn K, Hong WK, Lippman SM. Shin DM, et al. Among authors: khuri fr. Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-33-S19-37. Semin Oncol. 1997. PMID: 9427263 Clinical Trial.

7

Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract.

Spitz MR, Lippman SM, Jiang H, Lee JJ, Khuri F, Hsu TC, Trizna Z, Schantz SP, Benner S, Hong WK. Spitz MR, et al. J Natl Cancer Inst. 1998 Feb 4;90(3):243-5. doi: 10.1093/jnci/90.3.243. J Natl Cancer Inst. 1998. PMID: 9462683 No abstract available.

8

Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.

Shin DM, Glisson BS, Khuri FR, Ginsberg L, Papadimitrakopoulou V, Lee JJ, Lawhorn K, Gillenwater AM, Ang KK, Clayman GL, Callender DL, Hong WK, Lippman SM. Shin DM, et al. Among authors: khuri fr. J Clin Oncol. 1998 Apr;16(4):1325-30. doi: 10.1200/JCO.1998.16.4.1325. J Clin Oncol. 1998. PMID: 9552033 Clinical Trial.

9

Phase II trial of recombinant IFN-alpha2a with etoposide/cisplatin induction and interferon/megestrol acetate maintenance in extensive small cell lung cancer.

Khuri FR, Fossella FV, Lee JS, Murphy WK, Shin DM, Markowitz AB, Glisson BS. Khuri FR, et al. J Interferon Cytokine Res. 1998 Apr;18(4):241-5. doi: 10.1089/jir.1998.18.241. J Interferon Cytokine Res. 1998. PMID: 9568726 Clinical Trial.

10

Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Shin DM, Glisson BS, Khuri FR, Hong WK, Lippman SM. Shin DM, et al. Among authors: khuri fr. Semin Oncol. 1998 Apr;25(2 Suppl 4):40-4; discussion 45-8. Semin Oncol. 1998. PMID: 9578061 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

499 results

Search Page

Filters